Psychology

Maybelline New York Launches Brave Together: A Long-Term Program to Support Anxiety and Depression Worldwide

Retrieved on: 
Friday, September 25, 2020
Psychiatry, Mind, Psychology, Abnormal psychology, Psychiatric diagnosis, Disability, Mental health, Positive psychology, Social constructionism, Mental disorder, Anxiety

Depression affects more than 264 million.1Half of all mental health conditions start by age 14,2and with Covid-19, these numbers are rising.

Key Points: 
  • Depression affects more than 264 million.1Half of all mental health conditions start by age 14,2and with Covid-19, these numbers are rising.
  • We are launching the Maybelline Brave Together global cause program to help destigmatize anxiety and depression, provide critical one-on-one support and help everyone, everywhere bravely take on their world.
  • Over the past two years, Maybelline facilitated expert-led research and conducted focus groups to better understand the topic of mental health.
  • Maybelline has also been working with non-profit partners CRISIS TEXT LINE, JED, AND NAMI to have a tangible impact on people struggling with anxiety and depression.

ICD Hires New CIO Following 77% Growth in Money Market Assets on ICD Portal in First Half 2020

Retrieved on: 
Thursday, September 24, 2020
International Classification of Diseases, Psychopathology, World Health Organization, Mind, Psychology, Health

Bukacek's addition to the senior management team follows ICD's 77% growth in average daily balance of client assets on ICD Portal in the first half of 2020, ending June 30.

Key Points: 
  • Bukacek's addition to the senior management team follows ICD's 77% growth in average daily balance of client assets on ICD Portal in the first half of 2020, ending June 30.
  • "Tonya will help us securely deliver effective solutions in all market environments and will be integral to our success as ICD enters its next stage of growth."
  • Bukacek is leading ICD's technical operations team and support, both for customer-facing ICD production systems and for internal ICD infrastructure and technologies.
  • ICD is treasury's trusted, independent portal provider of money market funds and other short-term investments.

Proud Moments ABA Therapy Celebrates the Signature of A.10741, a Bill Allowing the State Education Department to extend Autism Therapist Permits for a Year

Retrieved on: 
Thursday, September 24, 2020
Mind, Psychology, Articles, European Trade Union Confederation, Free Trade Union Confederation of Latvia, International Trade Union Confederation, Aba, Applied behavior analysis, Play therapy, Behaviorism, Cuomo

As a result, these therapists could not begin or continue to provide care for children.

Key Points: 
  • As a result, these therapists could not begin or continue to provide care for children.
  • Proud Moments, as the largest provider of Applied Behavior Analysis (ABA) services in New York State, has been especially concerned about this problem.
  • So we are thrilled to announce today that Governor Cuomo has signed A.10741, a bill allowing the New York State Education Department to extend limited and provisional permits to ABA therapists (BCBAs and LBAs) for a year.
  • New York State is the epicenter of Proud Moments' clinical practice, with almost half of our BCBAs/LBAs practicing in New York.

Shara Sand, Psy.D. is recognized by Continental Who's Who

Retrieved on: 
Wednesday, September 23, 2020
Psychologist, Psychology, Psychotherapy, Doctor

is being recognized by Continental Who's Who as a Top Doctor in the field of Psychology for her accomplishments as a New York State Licensed Psychologist.

Key Points: 
  • is being recognized by Continental Who's Who as a Top Doctor in the field of Psychology for her accomplishments as a New York State Licensed Psychologist.
  • Dr. Shara Sand's practice offers a wide array of psychotherapeutic services designed to lead both adolescents and adults to live emotionally healthy, satisfied, and productive lives.
  • Dr.
  • Dr.

Canson® Infinity Ambassador Tania Franco Klein on disconnection, the American Dream and Rag Platine

Retrieved on: 
Wednesday, September 23, 2020
Papermakers, Canson, Klein, Tania, Psychology, Visual arts, Articles

Tania Franco Klein , born in 1990 in Mexico City, photographs isolation, psychological destabilization and other disorders most people dont want to talk about.

Key Points: 
  • Tania Franco Klein , born in 1990 in Mexico City, photographs isolation, psychological destabilization and other disorders most people dont want to talk about.
  • As a Canson Infinity Ambassador, she talks about experimentation with lighting, her favoriteCanson Infinity papers and how they facilitate turning her vision into a physical embodiment of her art.
  • Tania Franco Kleins autobiographical photography explores this burnout culture by taking topics of disconnection in everyday life, both within ourselves and others.
  • Franco Klein has been working with Canson Infinity since it was introduced onto the Mexican market and all her work and exhibitions are printed on Canson Infinity papers.

Arthur D. Little Announces New Board of Directors

Retrieved on: 
Wednesday, September 23, 2020
Professional services, Consulting, Arthur D. Little, Sustainability, Confidence, Articles, Mind, Psychology

While pursuing a dynamic, sustainable and profitable growth path, the company has continuously transformed itself.

Key Points: 
  • While pursuing a dynamic, sustainable and profitable growth path, the company has continuously transformed itself.
  • Ignacio Garca Alves, Chairman and Chief Executive Officer of Arthur D. Little, comments: I am very thankful for this renewed expression of confidence, and I am determined to continue the extraordinary development of Arthur D. Little during this new mandate.
  • I would also like to congratulate all new Board members as they take up their roles.
  • I am confident they will be a great support and a vital driving force in aggressively and sustainably developing our company.

World Market Outlook for the Workplace Stress Management Market to 2025

Retrieved on: 
Thursday, September 17, 2020
Articles, Mind, Psychology, Occupational health psychology, Workplace, Occupational safety and health, Industrial and organizational psychology, Occupational stress, Stress management, Psychological stress, Stress, Apathy

DUBLIN, Sept. 17, 2020 /PRNewswire/ -- The "Global Workplace Stress Management Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 17, 2020 /PRNewswire/ -- The "Global Workplace Stress Management Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Workplace Stress Management Market size is expected to reach 11.3 billion by 2025, rising at a market growth of 8.5% CAGR during the forecast period.
  • Stress at the workplace is among the most common types of stress.
  • Conditions such as anxiety, depression, fatigue, chronic headache, and apathy are among the common signs of excessive stress in the workplace.

INmune Bio, Inc. Awarded $2.9 Million NIH Small Business Innovation Research Grant to Support Phase 2 Study of XPro1595 in Patients with Treatment Resistant Depression

Retrieved on: 
Wednesday, September 16, 2020
Mind, Psychiatry, Psychology, Mood disorders, Psychiatric diagnosis, Abnormal psychology, Anhedonia, Major depressive disorder, Treatment-resistant depression, Biomarker, Depression

The grant will support a Phase 2 study of XPro1595 in patients with treatment resistant depression.

Key Points: 
  • The grant will support a Phase 2 study of XPro1595 in patients with treatment resistant depression.
  • Treatment resistant depression is a major problem affecting more than seven million patients in the U.S. alone, said CJ Barnum Ph.D., head of neurosciences at INmune Bio.
  • This Phase 2 multi-center, blinded, randomized study will enroll patients with treatment resistant depression that have biomarkers of inflammation and anhedonia (inability to feel pleasure).
  • ET on Tuesday, September 29, 2020 to provide additional information about the role of neuroinflammation in treatment resistant depression.

Phase II trial results demonstrated improvement in cognition with BI 425809 in adult patients with schizophrenia

Retrieved on: 
Monday, September 14, 2020
Biotechnology, Mental health, Health, Pharmaceutical, Clinical trials, Psychiatry, Schizophrenia, Abnormal psychology, Psychology, Psychopathology, Psychosis, Management of schizophrenia, Boehringer Ingelheim, Nootropics, Cognitive tests

Boehringer Ingelheim today announced the results from a 12-week, placebo-controlled Phase II trial, that demonstrated BI 425809 has met its primary endpoint.

Key Points: 
  • Boehringer Ingelheim today announced the results from a 12-week, placebo-controlled Phase II trial, that demonstrated BI 425809 has met its primary endpoint.
  • The latest trial results, along with an ongoing combination Phase II study of BI 425809 and adjunctive computerized cognitive training, will help determine the direction for BI 425809 in further schizophrenia research.3,4
    Prof. W. Wolfgang Fleischhacker, Medical University Innsbruck, Austria: The outcome of this trial is an important step forward in our understanding of cognition in schizophrenia.
  • The Phase II results of BI 425809 in cognitive impairment associated with schizophrenia are being further evaluated to assess how they will support the continued research and development for the treatment of schizophrenia.
  • The trial results for our investigational compound BI 425809 in schizophrenia are encouraging.